$54.04 arrow  Change: 0.48 %Chge: 0.90% Vol: 152,886
End Of Day Prices
High: 54.4 | Low: 53.79 | Open: 53.81 | Close: 54.04
52 Wk High: 80.36 | 52 Wk Low: 51.015 | Todays Pivot: 54.08
Sector: Healthcare and Pharmaceuticals add stock to watch list

CAH Chart

You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Related Healthcare and Pharmaceuticals Companies

Myriad Genetics 37.1 green arrow 40,761
Owens & Minor 30.14 green arrow 59,125
United Therapeutics Del 119.03 red arrow 13,420
Techne 128.49 green arrow 6,159
Lilly Eli 39.26 green arrow 432,295
Myriad Genetics 26.915 red arrow 81,735
Varian Med Sys 121.73 red arrow 23,064
Celgene 100.21 red arrow 157,621

Above is a small selection of related companies to Cardinal Health which compete alongside CAH within the Healthcare and Pharmaceuticals sector. To see more related companies to CAH, view our stock market today information page.

Online News For Cardinal Health

Cardinal Health Inc (NYSE:CAH) Is An Attractive Dividend Stock, Here’s Why

Over the past 10 years Cardinal Health Inc (NYSE:CAH) has returned an average of 2.00% per year from dividend payouts. The company is currently worth US$16.81b, and now yields roughly 3.52%. Should it have a place in your portfolio? Let’s take a look at ...

Should Cardinal Health Inc (NYSE:CAH) Be Your Next Stock Pick?

Cardinal Health Inc (NYSE:CAH) is a stock with outstanding fundamental characteristics. When we build an investment case, we need to look at the stock with a holistic perspective. In the case of CAH, it is a financially-sound company with a a strong track ...

Cardinal Health (CAH), CD&R to Jointly Invest in naviHealth

Cardinal Health, Inc. (CAH - Free Report) and Clayton, Dubilier & Rice (CD&R) recently announced a joint investment plan in naviHealth. Notably, 71% of Tennessee-based naviHealth was acquired by Cardinal Health in 2015 for a deal value of $290 million.

CAH Closer To FDA Approval, Another Alzheimer's Disease Drug Fails, VTVT Tanks

Today's Daily Dose brings you news about expanded FDA approval for Agilent's Dako PD-L1 IHC 22C3 pharmDx assay; Albireo Pharma's lead product candidate A4250 securing rare pediatric disease designation from the FDA for the treatment of progressive familial ...

Massachusetts-based show could replace Cah Talk on WBUR

WBUR says it's chosen McSweeney's to create a pilot show that could replace the Car Talk reruns the station now airs. The show would be hosted by Chris Monk of Arlington, who now runs McSweeney's Internet Tendency and who obviously has the Massachusetts ...

Want To Add This Quote To Your Site?

With our stock widgets you can add a Cardinal Health quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for CAH to choose from. Visit here to build your stock quote widget »